Form 8-K - Current report:
SEC Accession No. 0001437749-25-020959
Filing Date
2025-06-23
Accepted
2025-06-20 18:00:23
Documents
13
Period of Report
2025-06-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mnpr20250619_8k.htm   iXBRL 8-K 43773
  Complete submission text file 0001437749-25-020959.txt   178355

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20250617.xsd EX-101.SCH 3579
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20250617_def.xml EX-101.DEF 11807
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20250617_lab.xml EX-101.LAB 15858
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20250617_pre.xml EX-101.PRE 12022
15 EXTRACTED XBRL INSTANCE DOCUMENT mnpr20250619_8k_htm.xml XML 2947
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

EIN.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39070 | Film No.: 251062542
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)